Chester County News and Community Website
MyChesCo is the perfect source for businesses in Philadelphia to stay informed and up-to-date with the latest business news. We provide essential information to help businesses grow, network, and hire. Our content is concise and objective, making it easy to stay informed and make well-informed decisions.
MyChesCo provides comprehensive Philadelphia business news, giving you the latest information and updates about local businesses. Our content features news about upcoming events, articles, and resources to help businesses grow and expand. We provide in-depth coverage of relevant topics and trends in the local business community, making it easy to stay informed and up-to-date.
MyChesCo also features resources to help businesses network and hire. Our content focuses on helping businesses connect with each other and build relationships. We also provide resources to help businesses find new hires and fill job openings. We make it easy for Philadelphia businesses to network and find the best talent to move their businesses forward.
Our content is comprehensive and accessible, making it easy for businesses in Philadelphia to find the information they need. Our content is updated regularly, giving you the most up-to-date news and information about local businesses. We provide concise and objective content, making it easy to stay informed and make well-informed decisions about your business.
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has entered a strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SKINJECT™, its investigational doxorubicin-containing microneedle therapy …
Medicus Pharma Partners With Gorlin Syndrome Alliance to Expand Access to SKINJECT Read More
PHILADELPHIA, PA — Alterra IOS has closed a $150 million loan facility from funds managed by Blue Owl Capital Inc. (NYSE: OWL), marking Blue Owl’s first financing in the growing …
Alterra Secures $150 Million Blue Owl Loan to Expand Industrial Storage Footprint Read More
PHILADELPHIA, PA — Lula Commerce announced it has raised an $8 million Series A round led by SEMCAP AI, with additional backing from Rich Products Ventures, GO PA Fund, NZVC, …
Lula Commerce Secures $8 Million to Digitize America’s Convenience Stores Read More
PHILADELPHIA, PA — The City of Brotherly Love is turning positively magical this November as local venues prepare to celebrate the highly anticipated release of Wicked: For Good on November …
Philadelphia Goes Wicked: Four Spellbinding Ways to Celebrate the Movie Event of the Year Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced it will present at two upcoming investor conferences in November, highlighting its growing pipeline of T cell–engaging bispecific antibodies for solid …
Context Therapeutics to Showcase Cancer Immunotherapy Advances at Investor Events Read More
PHILADELPHIA, PA — Axalta Coating Systems Ltd. (NYSE: AXTA) reported solid third-quarter 2025 results, delivering record profitability despite a modest decline in overall revenue.
Axalta Posts Record Q3 Earnings Despite Dip in Sales Read More
PHILADELPHIA, PA — Dunkin’ is taking fans over the rainbow this season with a collaboration as bold as it is whimsical. Teaming up with Universal Pictures’ Wicked: For Good, the …
Dunkin’ Brews Up Oz-Inspired Magic With Wicked Collaboration Read More
HAARLEM, Netherlands & PHILADELPHIA, PA — Spaarne Gasthuis, a leading clinical teaching hospital serving part of the Greater Amsterdam region, announced it is fully digitizing its pathology practice with Concentriq® …
Dutch Hospital Fully Digitizes Pathology With Proscia’s Concentriq Platform Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) unveiled promising clinical data from its RESET-Myositis™, RESET-SSc™, and RESET-SLE™ trials evaluating rese-cel (resecabtagene autoleucel), reinforcing its potential to deliver long-lasting, drug-free …
Cabaletta Bio Reports Breakthrough Results in Autoimmune Disease Trials Read More
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients …
GSK Wins FDA Approval for Blenrep Combo in Advanced Multiple Myeloma Read More